Veles Therapeutics Private Limited - Company Profile

It is a research & development private limited company based in Bengaluru, Karnataka, India, established in 2022.
2022 Bengaluru, Karnataka, India Active
Last Updated:
Access Report
About Veles Therapeutics Private Limited

Veles Therapeutics Private Limited, a active private limited company, was established on 07 July 2022 in Bengaluru, Karnataka, India. Engaging in science research within the research & development sector, it holds CIN: U73100KA2022PTC163522. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Durga Devi Charllapally (Additional Director), Aparna Nandavaram (Director). Past directors included Divya Chandradhara. It is based at 17/51, 11Th Cross, 1St Main, Sanjeevini Nagar, Nagarabhavi, Moodalapalya, Bengaluru, Karnataka, 560072.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U73100KA2022PTC163522

  • Registration Number

    163522

  • Incorporation Date

    07 July 2022

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 3 Year, 8 Months
Company report

Veles Therapeutics Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Veles Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Veles Therapeutics Private Limited?
Current Directors
Name Designation Appointment Date Status
Durga Devi Charllapally Additional Director 25 Aug 2023 Current
Aparna Nandavaram Director 07 Jul 2022 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 25 Aug 2023 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Veles Therapeutics.

Enhance accessibility to Veles Therapeutics's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Veles Therapeutics revenue growth over time
Veles Therapeutics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Veles Therapeutics?

Unlock access to Veles Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Veles Therapeutics?

Veles Therapeutics has a workforce of 0 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Veles Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Veles Therapeutics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Veles Therapeutics
Recent Activity within the Organization
  • Director Appointment

    The activity Durga Devi Charllapally was appointed as a Additional Director was appointed as a Additional Director on 25 Aug 2023 & has been associated with this company since 2 years 6 months . was completed.

  • Director Appointment

    The activity Aparna Nandavaram was appointed as a Director was appointed as a Director on 07 Jul 2022 & has been associated with this company since 3 years 8 months . was completed.

  • Company Incorporation

    The activity Veles Therapeutics Private Limited was registered on 07 Jul 2022 with Roc Bangalore & aged 3 years 8 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Veles Therapeutics Private Limited?

The CIN of Veles Therapeutics Private Limited is U73100KA2022PTC163522.

Where is Veles Therapeutics Private Limited headquartered?

Veles Therapeutics Private Limited is headquartered at 17/51, 11Th Cross, 1St Main, Sanjeevini Nagar, Nagarabhavi, Moodalapalya, Bengaluru, Karnataka, 560072.

When was Veles Therapeutics Private Limited incorporated?

Veles Therapeutics Private Limited was incorporated on 07 July 2022.

Who are the current directors of Veles Therapeutics Private Limited?

The current directors of Veles Therapeutics Private Limited are

What is the primary industry of Veles Therapeutics Private Limited?

The primary industry of Veles Therapeutics Private Limited is Research & Development.

Is Veles Therapeutics Private Limited a listed company?

Veles Therapeutics Private Limited is unlisted.

What is the capital structure of Veles Therapeutics Private Limited?

The authorized capital of Veles Therapeutics Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available